A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients

Exclusion Criteria

• •1. has a history of substance dependence or abuse or whose symptoms are caused by other diagnosable mental disorders;
• •2. has a history of traumatic brain injury, seizures, or other known neurological diseases of the central nervous system;
• •3. taking antidepressants, stimulants, mood stabilizers, or received modified electroconvulsive therapy (MECT) or rTMS during the past three months;
• •4. having current suicidal or homicidal thoughts or any safety concern by research staff that cannot be managed during the trial;
• •5. taking dementia-related drugs, minocycline, and other drugs that may affect cognitive function;
• •6. Laboratory tests indicated significant abnormalities in blood routine, liver and kidney function, or other metabolic results;
• •7. pregnant or lactating women.